MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: BioPharmaceutical Drug Discovery & Development (Miscellaneous)
Kamada Ltd. (Nasdaq:KMDA)
Organization & Developments: Kamada Ltd
Parents
Kamada Ltd. (Nasdaq:KMDA)
Children
2022: Kamada uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins
2026: AI Exhaustion? 3 Healthcare Stocks With 38% EPS Growth That Could Be the Cure
Kamada develops and markets specialty plasma-derived protein therapeutics.
The company has one approved product for Alpha-1 Antitrypsin Deficiency (AATD) on the market
Jumps
Finance & Acquisitions: Kamada Ltd
Key People: Kamada Ltd